Screening solutions for patients with mild cognitive impairment through olfactory tests
Product Description
Alz Sniff
AI-based dementia early prediction program through olfactory stimulation
The Alz sniff is used to measure the fNIRS signal that changes during sensory stimulation testing, display the quantified signal change rate, and is used for the purpose of assisting medical personnel in determining the possibility of Alzheimer mild cognitive impairment (MCI) based on this.
In the case of the questionnaire method(SNSB, CERAD),
the accuracy decreases sharply if the users do not answer properly
fMRI
fMRI is not available for patients with implants
as it can produce distorted images
Alz sniff
In the case of the olfactory nerve, there is almost no deviation due to education or lifestyle, and the AI model calculates the pattern according to the measured value without requireing the examiner to interpret the questionnaire, ensuring consistent test quality.
* As a result of a test on 100 people, 80-90% accurate selection within 5 minutes
Without the need to calculate a score, Alz sniff's algorithm automatically analyzes and compares the test subject's baseline and data from the test to provide screening results.
Fast & Easy Process in Less Than 10 minutes
Provides the results with just 5 olfactory tests
Without the need to calculate a score, Alz sniff's algorithm automatically analyzes and compares the test subject's baseline and data from the test to provide screening results.